ADVERTISEMENT
Podcasts
Weighing Benefits and Challenges to Effectively Treat Atopic Dermatitis
09/16/2020
Steven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying patient adherence.
Reference:
Eichenfield LF, Armstrong A, Guttman-Yassky E, et al. Real-world effectiveness of dupilumab based on investigator global assessment (IGA) scores and peak pruritus numerical rating scale (PNRS) in an electronic medical records dataset. Poster presented at the 77th Annual Meeting of the Society for Investigative Dermatology (SID); May 8–11, 2019; Chicago, ILP.
Advertisement
Advertisement
Advertisement
Current Issue
June 2024
Volume 21
Issue 2
Advertisement
Advertisement
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter